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Abstract 
 Chronic obstructive pulmonary disease (COPD) is a common preventable and 
treatable disease characterized by symptoms of dyspnea, cough, and wheezing.  Many 
patients with COPD are on daily medications for their symptoms yet these symptoms 
continue to persist, impairing their quality of life.  Patients with COPD experience 
respiratory muscle weakness that contributes to dyspnea and an inability to participate in 
daily activities.  GOLD (2014) guidelines state that the goal of therapy in these patients is 
to reduce symptoms, increase participation in activities, and restore the highest level of 
independent functioning.  The guidelines recommend the use of inspiratory muscle 
training (IMT) in the plan of care for these patients in order to reduce symptoms and 
studies have shown that an incentive spirometer can be used to perform IMT effectively.  
The incentive spirometer is a simple, cost-effective device that encourages deep 
breathing, which promotes lung expansion.  The purpose of the EBP project was to 
improve quality of life and dyspnea in adult patients, ages 45-70, with COPD through the 
daily use of incentive spirometry.  The project was based on the GOLD (2014) 
guidelines.  The St. George’s Respiratory Questionnaire and Visual Analogue Scale for 
breathlessness were administered before and after the protocol and scores were 
compared.  The project showed a decrease in dyspnea and improvement in quality of life 
after an eight week intervention period.  The results of this project demonstrated that 
including IMT in the plan of care for patients with COPD can reduce dyspnea and  
improve quality of life, leading to quality, cost-effective, accessible care and optimal 
outcomes in these patients.
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Chapter 1 
Introduction and Overview of the Problem of Interest 
Chronic Obstructive Pulmonary Disease (COPD) is a significant chronic disease 
affecting about 1.5 million individuals in the United States (Yang, Taylor & Blackstock, 
2010).  Approximately 25% of individuals with COPD are admitted to an acute care 
hospital each year with an exacerbation of the disease (Yang, Taylor & Blackstock, 
2010).  The estimated direct costs of the disease are $29.5 billion with exacerbations 
accounting for the greatest proportion of the burden (GOLD, 2014).  COPD is the fourth 
most common cause of death in the United States and is expected to be the third most 
common cause of death by the year 2020 (Heydari, Farzad & Hosseini, 2013).  Mortality 
from the disease has more than doubled over the past twenty years (Celli, MacNee, 
Augusti, Anzueto, Berg, Buist,…ZuWallack, 2004).   
COPD has been known to substantially impair quality of life and increase the risk 
of premature death (Petrovic, Reiter, Zipko, Pohl & Wanke, 2012).  Patients with COPD 
experience respiratory muscle weakness which contributes to the sensation of dyspnea 
(Heydari, Farzad & Hosseini, 2013).  Dyspnea is a cardinal symptom of the COPD and a 
major cause of disability and anxiety associated with the disease (GOLD, 2014).  Daily 
activity is frequently limited and health related quality of life is reduced due to dyspnea 
(Shinde, Kiran, Khatri & Hande, 2012).  The Disability Adjusted Life Year (DALY) 
estimates the fraction of disability attributable to major diseases and COPD is projected 
to be the seventh leading cause of DALY’s lost worldwide by 2020 (GOLD, 2014).   
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 Early literature on the use of inspiratory muscle training in patients with COPD 
presented a mixed opinion but current GOLD (2014) guidelines recommend the use of 
inspiratory muscle training as part of a pulmonary rehabilitation program for these 
patients to improve dyspnea and quality of life (Geddes, Reid, Crowe, O’Brien & Brooks, 
2005).   
 This evidence-based practice change project focuses on the use of incentive 
spirometry for inspiratory muscle training to decrease dyspnea and improve quality of life 
in individuals with COPD.  The project and it’s implication for advanced nursing practice 
will be discussed in this paper. 
Background 
COPD is a common preventable and treatable disease that is characterized by 
persistent airflow limitation, air trapping, and hyperinflation of the lungs, which puts the 
inspiratory muscles at a mechanical disadvantage (GOLD, 2014; Shinde, Kiran, Khatri & 
Hande, 2012).  The airflow limitation is usually progressive and associated with a chronic 
inflammatory response in the airways and lungs due to noxious particles and gases 
(GOLD, 2014).  The disease can be characterized by chronic cough, dyspnea, wheezing, 
and increased mucous secretions and is associated with a functional weakness of the 
inspiratory muscles (Satani, Khuman & Nambi, 2013).  COPD can substantially impair 
the individual’s quality of life and increase the risk of premature death (Petrovic, Reiter, 
Zipko, Pohl & Wanke, 2012).   
COPD produces obstruction to the flow of air which affects the mechanical 
function and gas exchange of the lungs (Satani, Khuman & Nambi, 2013).  These patients 
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also experience alterations in the mechanics of the chest wall that reduces the 
effectiveness of the diaphragm and increases the work of breathing (Shinde, Kiran, Khatri 
& Hande, 2012).  The respiratory muscles must work harder in order to overcome this 
resistance which in turn leads to respiratory muscle weakness (Satani, Khuman & Nambi, 
2013).  Respiratory muscle weakness contributes to hypercapnia, dyspnea, oxygen 
desaturation, and reduced walking distance (Gosselink, DeVos, van den Huevel, Segers, 
Decramer & Kwakkel, 2011).  Dyspnea is an important and most debilitating symptom in 
these patients and frequently limits daily activity and reduces a patient’s health related 
quality of life (Shinde, Kiran, Khatri & Hande, 2012).  Drug therapy is the mainstay in 
treatment for patients with COPD, followed by physical rehabilitation, which has been 
the only method proven to reduce dyspnea (Satani, Khuman & Nambi, 2013).  
Respiratory rehabilitation has been recognized as an important part of the management in 
patients with COPD (Shinde, Kiran, Khatri & Hande, 2012).  It is a multidisciplinary 
program of care that can be individually tailored and designed for each patient to 
optimize physical and social performance, and patient autonomy (Celli et al., 2004). 
Controlled breathing is included in respiratory rehabilitation programs and has been 
shown to relieve dyspnea by increasing strength and endurance of the respiratory muscles 
(Gosselink, 2003).  The aim of respiratory rehabilitation is to improve ventilation and gas 
exchange and it has been shown to improve respiratory function, decrease dyspnea, and 
improve exercise tolerance and quality of life in patients with COPD (Shinde, Kiran, 
Khatri & Hande, 2012).  Respiratory rehabilitation is recommended by the GOLD 
guidelines (2014) for a non-pharmacologic therapy in patients with COPD.  Inspiratory 
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muscle training (IMT) is an important and common component of respiratory 
rehabilitation that improves the strength and endurance of the respiratory muscles (Satani, 
Khuman, Devi & Nambi, 2013).  Studies have shown that placing a load on respiratory 
muscles during inspiration can increase the strength of respiratory muscles, causing a 
meaningful reduction in dyspnea (Heydari, Farzad & Hosseini, 2013).  GOLD guidelines 
(2014) list the many benefits of respiratory rehabilitation which include improved quality 
of life, reduced anxiety and depression associated with COPD, improved survival, and 
reduced sensation of breathlessness.  One of the devices used for inspiratory muscle 
training is the incentive spirometer, which offers resistance while performing inspiration 
(Satani, Khuman, Devi & Nambi, 2013).  The incentive spirometer is a simple, cost-
effective device which provides visual feedback to the patient while performing 
inspiration so that the patient can achieve goals (Satani, Khuman, Devi & Nambi, 2013).  
Incentive spirometry encourages deep breathing and sustained inspiration, a more 
controlled flow of breathing, and greater enthusiasm to practice IMT in patients (Satani, 
Khuman, Devi & Nambi, 2013).   The device is designed to mimic natural sighing or 
yawning by encouraging the patient to take slow, long, and deep breaths (Restepro, 
Wettstein, Wittnebel & Tracy, 2011).  This mechanism decreases pressure in the lungs, 
promoting increased lung expansion and when repeated on a regular basis, has the ability 
to prevent or reverse atelectasis (Restepro, Wettstein, Wittnebel & Tracy, 2011).  Studies 
have shown that the daily use of incentive spirometry resulted in improved quality of life 
and decreased dyspnea in patients (Basoglu, Atasever & Backagolu, 2005; Satani, 
Khuman, Devi & Nambi, 2013). Guidelines for the use of incentive spirometry 
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recommend the use of the device in the presence of pulmonary atelectasis or in conditions 
that may predispose individuals to atelectasis when used in the presence of restrictive 
lung defects (Restepro, Wettstein, Wittnebel & Tracy, 2011).   
Significance  
COPD is a leading cause of morbidity and mortality worldwide and results in an 
economic and social burden that is substantial and continues to increase (GOLD, 2014).  
The prevalence and burden of the disease are expected to increase in the coming years 
due to the continued exposure of COPD risk factors and the aging of the population 
(GOLD, 2014).  COPD is a major health problem in the United States with the mortality 
rate rising yearly (Halpern, Stanford & Borker, 2003).  The disease is associated with a 
significant economic burden as well.  In the United States, the economic burden of COPD 
is estimated at $29.5 billion for direct costs and exacerbations of the disease account for 
the greatest proportion of the total burden to the healthcare system in the United States 
(GOLD, 2014).  In addition to direct costs, COPD has been shown to have a major 
impact on non-medical costs as well, due to lost productivity, at a cost of $14.1 billion 
(Halpern, Stanford & Borker, 2003).  When taking into consideration the burden that this 
disease places on patients with the disease and the healthcare system, one can see the 
significance of the problem in primary care and the importance for healthcare providers 
to work with these patients to improve respiratory muscle function.  COPD remains a 
chronic public health problem and its systemic effects have been recognized in other 
body systems which can further impair the lives of these patients, resulting in lost work 
days (Heydari, Farzad & Hosseini, 2013).  One-third of patients reported that they were 
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prevented from going to work because of their COPD symptoms and approximately 
seven percent of caregivers of these individuals have reported work loss (Halpern, 
Stanford & Borker, 2003).  Airflow limitation and hyperinflation affect cardiac function 
and gas exchange, inflammatory mediators in the circulation may contribute to skeletal 
wasting and cachexia, and the disease may irritate or worsen comorbidities such as 
ischemic heart disease, heart failure, osteoporosis, normocytic anemia, diabetes, 
metabolic syndrome, and depression (GOLD, 2014).  Individuals with the disease also 
experience a social burden as well and are limited in their participation in daily activities 
and many may experience social isolation due to their limitations (GOLD, 2014).  
Advanced practice nurses (APN’s) play an important role in identifying potential 
candidates for respiratory muscle training and in facilitating and reinforcing the material 
learned in the program (Heydari, Farzad & Hosseini, 2013).  Advanced practice nurses 
have the ability to define, identify and analyze outcomes to improve the health status of 
individuals and populations (Curley & Vitale, 2012).  Advanced practice nurses can 
facilitate care processes that can result in the achievement of outcomes for individuals or 
groups of patients through education, counseling, direct clinical practice, and 
coordination of care (Hamric, Spross & Hanson, 2009).  When considering the morbidity 
and mortality of COPD, the APN can use the information to find available resources and 
develop innovative interventions for patients in order to improve their quality of life and 
decrease the sensation of dyspnea they experience (Curley & Vitale, 2012).  
System and Population Impact 
 COPD affects individuals from all socioeconomic levels and not all patients have  
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access to formal rehabilitation programs which makes it important for the advanced 
practice nurse to facilitate these services for patients in need (Heydari, Farzad & 
Hosseini, 2013).  Using a simple tool such as incentive spirometry for respiratory 
rehabilitation can greatly improve the ability of the advanced practice nurse to provide 
these individuals with more feasible and accessible care (Heydari, Farzad & Hosseini, 
2013).  The device is inexpensive and easy to use, which makes its use in areas of health 
disparities, such as in the underinsured and uninsured, essential (Restepro, Wettstein, 
Wittnebel & Tracy, 2011).   
Question Guiding Inquiry 
Considering the importance of reduction of dyspnea and improvement in quality 
of life for patients with COPD, the advanced practice nurse may ask the following 
question: “In adults ages 45-70 with COPD, does the daily use of incentive spirometry 
result in decreased dyspnea and improved quality of life over an eight week period?” 
Purpose 
The population of interest for this evidence-based project are male and female 
adults, ages 45-70, with a documented diagnosis of COPD, are compliant with care, and 
are English speaking.  These patients may currently be using medications for COPD, 
which may include bronchodilators, long and short acting beta-agonists, systemic 
corticosteroids, and inhaled corticosteroids (ICS).  Patients excluded from the proposed 
project would be those with co-morbid conditions, non-compliant patients, and those with 
a history of pneumothorax.   
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The intervention the PICO-T is proposing is the daily use of incentive spirometry 
as a form of inspiratory muscle training over an eight week period combined with 
telephone follow up every two weeks, to reduce dyspnea and improve quality of life in 
patients with COPD.  The outcome of interest is the reduction of dyspnea and improved 
quality of life, self-reported by patients, using St. George’s Respiratory Questionnaire 
(2005) and a Visual Analogue Scale (1999) for dyspnea.  These measurements would be 
evaluated at the start and end of the project.  Patients will also be provided with a daily 
symptom diary to record their symptoms and to document the use of the intervention in 
order to reduce the potential for participant recall bias.  The follow up telephone calls 
every two weeks would be used as a way to assess compliance and to respond to any 
concerns or questions at that time.   
Aims/Objectives 
The objective of the project is to implement an evidence based practice protocol 
using incentive spirometry as a means of inspiratory muscle training when treating 
patients who present to the urgent care setting with complaints of dyspnea and impaired 
quality of life.  The objective is to determine if the use of daily incentive spirometry 
would result in patients reporting a decrease in dyspnea and improvement in their quality 
of life.  Intended users of the protocol would include advanced practice nurses, physician 
assistants, and physicians.  Impaired functional status and dyspnea are critical features of 
COPD and the goals of using respiratory rehabilitation in these patients is to reduce 
symptoms, improve activity, and restore the highest level of independent function 
possible (Lan, Chu, Yang, Lee, Wu & Wu, 2013).  Exercise capacity is important because 
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it directly correlates with mortality in patients with COPD, so if this can be improved, 
mortality from the disease can be reduced and thus, hopefully improve the health of this 
population (Lan, Chu, Yang, Lee, Wu & Wu, 2013).  When evaluating the many benefits 
of respiratory muscle training in patients with COPD and upon review of evidence 
presented in clinical guidelines, it is essential that this is included in the plan of care for 
these patients in order to improve their quality of life and decrease associated symptoms 
and mortality from the disease. 
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Chapter 2 
Review of the Evidence/Literature 
 Patients with COPD experience respiratory muscle weakness that contributes to 
dyspnea, which is the most debilitating symptom in these patients and can reduce health 
related quality of life (Gosselink, DeVos, van den Huevel, Segers, Dekramer& Kwakkel, 
2011; Shinde, Kiran, Khatri & Hande, 2012).  Guidelines recommend the use of respiratory 
rehabilitation as a therapy in patients with COPD (GOLD, 2014).  COPD is the leading 
cause of morbidity and mortality in the world and has resulted in an economic and social 
burden that is substantial and continues to increase daily (GOLD, 2014).  Considering this, 
it is important for clinicians to seek out the current best evidence and apply it in their daily 
practice in order to improve outcomes in this population.  One of the most important 
reasons for implementing evidence based practice (EBP) is that it leads to the best quality 
of care and the best patient outcomes (Melnyk & Fineout-Overholt, 2011).   
Evidence evolves continually, so it is important that clinicians include the latest 
evidence in their practice (Melnyk & Fineout-Overholt, 2011).  Without current best 
evidence, practice can become rapidly outdated, which can be detrimental to patients 
(Melnyk & Fineout-Overholt, 2011).  The purpose of a literature review is to provide 
information about existing current evidence related to a question of inquiry (Melnyk & 
Fineout-Overholt, 2011).  The literature review supports the value or the need to study a 
phenomena of interest and is used to present data that support the need for the project and 
how the project is needed to address the findings (Moran, Burson & Conrad, 2014).  This 
literature review was performed based on a systematic, thorough, and rigorous approach in 
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order to ensure the quality of evidence obtained.  The literature obtained describes concepts 
related to the use of inspiratory muscle training in COPD patients in relation to improving 
inspiratory muscle strength and improving dyspnea and quality of life as well as to identify 
areas where further inquiry is needed.  
Methodology 
 The purpose of this section is to briefly describe the strategy that was used to select 
and review the articles that were used in the literature review.  In order to find evidence to 
support the evidence based practice project, a systematic database literature search that 
encompassed the years 2005 to 2014 was performed using the keywords or terms  “chronic 
obstructive pulmonary disease”, “COPD guidelines”, “incentive spirometry guidelines”, 
“incentive spirometry”, “inspiratory muscle training”, “quality of life”, and “dyspnea”.  
Delimiters were used during the literature search such as “incentive spirometry and 
COPD”, “inspiratory muscle training and COPD”, and “inspiratory muscle training and 
incentive spirometry”.  Databases searched were CINAHL, Academic Search Premier, 
Medline, and PubMed. The databases were chosen due to the fact that they are well known 
and credible sources that contain current information related to the area of interest in the 
evidence based practice project.  Inclusion criteria for the search were adults, male and 
female patients, ages 45-70, diagnosed with COPD.  Those studies not published in English 
or not using inspiratory muscle training were excluded.  Literature that appeared as letters 
to the editor was also excluded.  The above mentioned search terms resulted in twenty four 
results in Academic Search Premier, 164 results in CINAHL, 164 results in Medline, and 
287 results in PubMed.  Abstracts of the results were then read to determine if the area of 
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interest, inclusion and exclusion criteria, intervention, and outcomes of interest were 
similar to those in the proposed evidence based practice project.  After a review of the 
literature, nine articles were identified that met the criteria to support the proposed evidence 
based practice project.  Those that were chosen are Level I and II evidence which consist 
of randomized controlled trials, systematic reviews, meta-analyses, and clinical guidelines, 
because these are the strongest levels of evidence and are the least biased way to 
demonstrate with confidence that the interventions will consistently bring about an 
outcome (Melnyk & Fineout-Overholt, 2011).    
Findings (Critical Appraisal of the Literature) 
Randomized Controlled Trials 
 Basoglu, Atasever & Backagoglu (2005) conducted a randomized controlled trial 
to evaluate the effects of incentive spirometry on pulmonary function tests, arterial blood 
gases, dyspnea, and health related quality of life in patients with COPD.  The incentive 
spirometer was used as an inspiratory muscle trainer in this study.  
 The participants in the study were thirty two (n=32) patients hospitalized with an 
exacerbation of COPD and were either given medications for COPD and asked to 
undertake incentive spirometry (n=16) or given only medical treatment (n=16).  The 
intervention and comparison were the addition of daily use of incentive spirometry in 
addition to typical COPD medications and the outcome was to determine if there was an 
improvement in pulmonary function tests, arterial blood gases, dyspnea, and quality of life.  
Patients received follow up telephone calls every two weeks during the intervention period 
and had a follow up visit at two months from the start of the intervention period.   
13 
 
 
 After patients were recruited for the study, they were randomized to either the 
medical treatment group (n=16) or the group with incentive spirometry plus medical 
treatment (n=16), through a computer random generator.  Due to the computerized 
randomization, the study and control groups were not matched, however when 
demographics for both groups were reviewed, they appeared similar and a chart was 
provided to substantiate this.  There was no mention of concealment or blinding in the 
study.  Prior to the beginning of the study, a power calculation was done.   The authors 
provided the number of patients who withdrew from the study and the reasons for 
withdrawal.   
 Participants in the study had arterial blood gases and pulmonary function tests and 
completed visual analogue scales (VAS) for breathlessness and the St. George’s 
Respiratory Questionnaire (SGRQ) at the beginning and end of the study and the authors 
provided a chart to compare the pre- and post-treatment values for these.  P values were 
reported as p<0.0001 for both.  Based on the above, the study should be considered valid 
with some caution.  
 The study states that the researchers used the student’s t-test to analyze parametric 
measures.  The analysis of categorical variables was done using the X2 test, Fisher’s exact 
test, or the Mann-Whitney U-test.  Results are expressed with a 95% confidence interval 
(CI) and p values are expressed when there was statistical significance.  Between the two 
groups, the activity impact and total SGRQ scores were improved by the use of incentive 
spirometry (95% CI; p<0.0001).  VAS scores in the incentive spirometry treatment group 
decreased from 8.3 +/- 1.2 to 7.7 +/- 1.4.  The PaCO2 decreased in the incentive spirometry 
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group (95% CI; p= 0.02) and the PaO2 increased as well (95% CI; p=0.01).  These findings 
show that the use of incentive spirometry along with medical treatment improved arterial 
blood gases, dyspnea, and health related quality of life.  The use of incentive spirometry 
was shown to increase inspiratory muscle performance in this study.  The authors do 
suggest that the study may be performed in the future using a larger number of subjects 
and also in stable COPD patients.  There were several limitations noted in the study, one 
of these being a small amount of participants.  Results would vary in relation to a larger 
number of participants and may provide more support for the intervention.  Most 
participants in the study were males.  This is not representative of most COPD patients 
because the disease affects both males and females.  Based on the findings, the study should 
be considered reliable with some caution.   
 Petrovic, Reiter, Zipko, Pohl & Wanke (2012) conducted a randomized controlled 
trial to analyze the effects of inspiratory muscle training (IMT) on exercise capacity and 
dyspnea in patients with COPD.  The participants in the study were twenty (n=20) patients 
with COPD who were recruited from an outpatient clinic and either underwent IMT or 
didn’t.  The outcomes measured were inspiratory muscle capacity and dyspnea.  The timing 
of follow up was eight weeks.   
 After participants were recruited into the study, they were randomized to either the 
IMT group (n=10) or the control group (n=10).  Although the authors state that the 
participants were randomized to the groups, no mention is made as to how the 
randomization occurred or if there was blinding.  There is no mention made of a power 
calculation or ITT analysis being performed prior to the start of the study.  There was no 
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mention of patient withdrawal from the study.  A chart was provided to show the 
characteristics of both groups at baseline and both groups appear similar.  The intervention 
and control management were described in the article.  Based on the above, the study  
should be considered valid with some caution.  
 The study states that the authors used the Shapiro-Wilk test for preliminary testing 
to evaluate if the grouped data were normally distributed (p<0.05).  Results are expressed 
with a 95% CI and p values are expressed when there was statistical significance.  The IMT 
training group showed a significant increase in inspiratory muscle performance after eight 
weeks of daily IMT when compared to the control group (95% CI; p<0.001).  The level of 
dyspnea showed a significant decrease after eight weeks of daily IMT (95% CI; p<0.01).  
Inspiratory capacity also increased in the treatment group when compared to the control 
group (95% CI; p<0.001).  Charts were provided for comparison of spirometric data values 
at the start and end of the intervention period.  ANOVA was done for analysis of between 
group effects analysis.  No limitations of the study were mentioned by the authors, 
however, the small number of participants can be considered a limitation.  Another 
limitation of the study was that participants only performed inspiratory muscle training 
once per day.  Based on the above, the study should be considered reliable with some 
caution.  
 Heydari, Farzad & Hosseini (2013) conducted a randomized controlled trial to 
examine the effect of incentive spirometry on pulmonary rehabilitation in COPD patients 
compared to using inspiratory resistive muscle training technique.  The participants in the 
study were 30 (n=30) patients with COPD that were randomized to either an IMT group 
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(n=15) or an incentive spirometry group (n=15).  The outcomes measured were respiratory 
function test values.  The timing of the follow up was four weeks.   
 After patients were recruited for the study, they were randomized to either the IMT 
group (n=15) or the incentive spirometry group (n=15), however no mention is made as to 
how the randomization occurred.  Prior to the beginning of the study, a power calculation 
was done in order to reduce the risk of a Type II error.  There was no mention of any patient 
withdrawal and all participants completed the study.  There is no mention of blinding in 
the study.  A chart was provided to show baseline characteristics of both groups and both 
groups appear similar except that there were more male subjects than female subjects in 
both groups.  P values are provided in this chart.  The intervention and control management 
were described in the article.  Based on the above, the study should be considered valid 
with some caution.  
The study states that ANOVA was performed for within group analysis of variance.  
Results are expressed with a CI of 95% and p values are expressed where there was 
statistical significance.  The findings showed significant differences between the mean 
values of each respiratory function test for both techniques (95% CI; p<0.001).  For the 
value of peak expiratory flow rate (PEFR), incentive spirometry was shown to be more 
effective than IMT (95% CI; p=0.021).  A chart was provided to compare respiratory 
function tests before, during, and after intervention, with p values listed.  It was determined 
by the authors that breathing exercises improved dyspnea in the incentive spirometry group 
as a result of improved inspiratory muscle performance.  The authors of the study listed 
that they limited time to pursue long term effects of the interventions and that the findings 
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may not be generalizable to patients with severe COPD or an unstable cardiovascular 
status.  Based on the above, the study should be considered reliable with some caution. 
The findings of the appraised RCT’s support the proposed evidence based practice 
project because the goal of the project is to use incentive spirometry as an inspiratory 
muscle trainer to improve quality of life and decrease dyspnea in COPD patients.  Results 
from these studies show that inspiratory muscle training can be an important aspect of 
treatment in this population of patients in order to improve patient outcomes.   
Systematic Reviews/Meta-Analyses 
 Geddes, Reid, Crowe, O’Brien & Brooks (2005) conducted an analysis of nineteen 
randomly controlled trials (RCT’s) to determine the effect of IMT on inspiratory muscle 
strength and endurance, exercise capacity, dyspnea, and quality of life for adults with 
COPD.  The criteria for considering studies to include in the review was explained and 
only studies that used randomized design to allocate patients to groups, English 
publications, and adult participants were used.  The authors performed a structured search  
of Medline and CINAHL from the inception dates of the databases up to 2003 for limits.  
The search strategy was included in the text of the review.  Reference lists from pertinent 
articles and books were searched, authors were contacted personally, and targeted journals 
were hand searched to identify any relevant articles for inclusion.  Studies were chosen if 
they compared IMT to another comparison group.  A flow chart was provided that showed 
the amount of RCT’s that were included and excluded and the reasons as to why.  Data 
from the articles was extracted independently by two reviewers onto data abstraction forms.  
Methodological quality of the studies was assessed by two reviewers using criteria by Jadad 
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et al. for randomization, double-blinding, withdrawals/dropouts, and group similarities at 
baseline.  No mention was made as to the settings for the included RCT’s.  Outcomes of 
interest in the review were inspiratory muscle strength, dyspnea, and exercise capacity.  A 
table of studies was provided that compared the various modes of IMT that were used.  
Sensitivity analyses were performed in the presence of significant heterogeneity to 
determine the robustness of the findings. Funnel plots were presented in the review to 
decrease the possibility of publication bias.  Based on the above, the systematic review 
should be considered valid.   
 Data was analyzed using computer software and outcomes were analyzed as 
continuous outcomes using the random effects model to calculate the mean difference and 
95% CI.  Main findings of the review showed inspiratory muscle strength improved by 
12.3cm H2O (95% CI; p<0.00001) in groups using targeted IMT and inspiratory muscle 
endurance increased by 1.0kPa (95% CI; p=0.005) in these groups as well.  Dyspnea was 
also found to be improved in these groups (95% CI; p<0.00001).  A large clinically 
significant change was found for an increase in quality of life for those in IMT groups.   
Main findings of the review were that targeted IMT significantly improves 
inspiratory muscle strength, inspiratory muscle endurance, quality of life, and decreases 
dyspnea in patients with stable COPD.  All results were tested for heterogeneity and the 
authors acknowledged that there was significant heterogeneity (p<0.00001) between the 
studies in regards to the different forms of IMT.  Based on the above, the systematic review 
should be considered reliable.   
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 Gosselink, De Vos, van den Huevel, Segers, Decramer & Kwakkel (2011) 
conducted a meta-analysis of thirty two RCT’s  to investigate the effect of IMT as a single 
therapy or added to general exercise training, and identify the most appropriate training 
modality in terms of strength or endurance training for IMT.  The criteria for considering 
studies to include in the review was explained and only studies that used randomized design 
to allocate patients to groups were used.  The authors performed a standardized search of 
databases using the publication dates up to May 2009 for limits.  The search strategy was 
included in an online supplement.  No language restrictions were used in the search.  The 
search was performed by two independent reviewers and if data were not in a form  
suitable for pooling, authors were contacted for additional information.  Studies were 
selected if they were randomized to groups, included patients with COPD, used IMT or 
respiratory muscle endurance training, or if outcomes were described in terms of 
inspiratory muscle strength, dyspnea, or health related quality of life.  No flow chart was 
provided to show the inclusion and exclusion of the RCT’s but the process was explained 
in the analysis.  The I2 statistic was calculated to determine heterogeneity and funnel plots 
were presented in the review to decrease the possibility of publication bias. Heterogeneity 
was defined if the I2 was beyond 50%.  Based on the above, the meta-analysis should be 
considered valid.   
 Data was analyzed using summary effect size (SES).  The meta-analysis for 
inspiratory muscle strength demonstrated a significant increase of 13 mm H2O (SES 0.68; 
95% CI 0.54-0.82; p<0.001) in the treatment group compared to the control group.  A 
significant effect was found for dyspnea scores (SES -0.45; 95% CI -0.66- -0.24; 
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p<0.00001) in the IMT training group.  A significant improvement in quality of life was 
also seen for the IMT training group (SES 0.34; 95% CI 0.09-0.60; p<0.01).  Main findings 
of the review were that IMT was superior to endurance training for improving inspiratory 
muscle strength, dyspnea, and quality of life.  All results were tested for heterogeneity and 
the authors acknowledged that there was significant heterogeneity between the studies in 
regards to the superiority of IMT for COPD patients.  Based on the above, the meta-analysis 
should be considered reliable.   
 The findings of the systematic review and meta-analysis support the proposed 
evidence based practice project because the goal of the project is to use incentive 
spirometry as an inspiratory muscle trainer to improve quality of life and decrease dyspnea 
in COPD patients.  Results from these studies show that inspiratory muscle training can be 
an important aspect of treatment in this population of patients in order to improve patient 
outcomes.  The evidence has shown that IMT is an effective treatment modality in COPD 
patients to improve inspiratory muscle strength, dyspnea, and quality of life.   
Guidelines 
 The Global Initiative for chronic Obstructive Lung Disease (GOLD) guideline 
(2014) were reviewed using the AGREE instrument.  GOLD (2014) clearly stated that the 
objective of the guideline is to provide recommendations for management of COPD based 
on the best scientific information available.  Guideline developers are clearly listed and are 
known to have expertise in COPD research and patient care and represent a variety of 
disciplines.  The areas the guideline covers are specifically described throughout and 
targeted users are defined as “those working in clinical settings anywhere in the world 
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providing COPD treatment” (p. xiv) and for healthcare professionals to use as a tool to 
implement effective management programs based on available health care systems.  The 
guideline was first piloted in 2001 with the first GOLD report.   
 Systematic methods were identified to search for evidence to develop future 
updated versions.  Members of the committee evaluate abstracts and indicate if the 
scientific data impacts on the recommendations of the GOLD report.  The methods for 
formulating recommendations were clearly defined.  Criteria for selecting the evidence is 
clearly defined in the guideline.  Health benefits, risks, and side effects of the various 
treatment modalities were considered with discussion of treatments.  Recommendations 
are linked to supporting levels of evidence.  Review of the guideline occurs internally and 
externally.  Updates are made as new data becomes available and the GOLD science 
committee meets twice yearly to discuss the addition of the data to the GOLD report, either 
as a reference or to change the report.   
 The guideline is specific and unambiguous and clearly identifies management 
options.  Key recommendations are identified throughout using various levels of evidence 
and are presented clearly using charts and tables for easy identification.  Organizational 
barriers and cost effectiveness are not specifically mentioned.  No conflicts of interest were 
identified.  
 Recommendations are made for pulmonary rehabilitation in COPD patients to 
reduce symptoms, improve quality of life, and increase physical participation in everyday 
activities which closely relates to the proposed evidence based practice project.  GOLD 
recommends that IMT can be beneficial in patients with COPD.  Differing types of non-
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pharmacologic therapies are included for application with COPD patients.  The social and 
economic burden of the disease is discussed.  The GOLD guideline is appropriate for the 
proposed practice change project and closely relates to the population indicated.  The 
recommendations can be used by healthcare providers and applied to the population of 
COPD patients to improve their quality of life, decrease dyspnea, and to ensure that best 
practices are used to improve outcomes in this population.   
 The AARC Clinical Practice Guideline on Incentive Spirometry (2011) was 
reviewed using the AGREE instrument.  Restepro, Wettstein, Wittnebel & Tracy have  
presented the guideline to provide users with the proper use of the tool, indications and 
contraindications for use, monitoring during use, frequency of use, infection control 
methods, and key recommendations.  Guideline developers are noted to be individuals from 
various hospitals and medical centers and all are respiratory therapists.  Targeted users are 
identified as those in critical care, acute care inpatient settings, extended care and skilled 
nursing facilities, and those in home care.  No piloting of the guideline is mentioned.   
 Systematic methods were identified to search for evidence and the criteria for 
selecting the evidence was defined.  Methods for formulating key recommendations were 
clearly defined using the Grading of Recommendations Assessment, Development, and 
Evaluation scoring system (GRADE) and the recommendations are linked to supporting 
evidence.  Health benefits and risks are considered and noted.  No mention is made of the 
review process for the guideline.  No procedures are listed for updating. There are no tables 
for dissemination of recommendations but they are clearly listed at the end of the guideline. 
No sources of funding are indicated and no conflicts of interest were identified.  
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 The recommendations can be applied to the proposed evidence based practice 
project using incentive spirometry and can ensure that it is done with proper technique and 
frequency.  It is recommended that a volume oriented device be used, which is the typical 
device used in healthcare today.  No barriers to application were identified and incentive 
spirometry has been shown to be an inexpensive, convenient tool to use and has been used 
routinely in postoperative patients to prevent complications.  The target population can 
benefit from the use of the device and it is applicable to the population and users considered 
in the proposed practice project.   
Integrative Review of the Literature 
 After a thorough review of the literature, it appears that there is evidence to 
support the implementation of the proposed evidence based practice project.  The clinical 
usefulness of the findings in the review provide APN’s with the ability to advance care in 
this population.  Patients with COPD experience respiratory muscle weakness which may 
contribute to dyspnea and decreased quality of life (Heydari, Farzad & Hosseini, 2013).  
Improvement in care for this specific population must include the addition of pulmonary 
rehabilitation in order to improve quality of life (GOLD, 2014).  Multiple systematic 
reviews and RCT’s suggest the use of IMT for COPD patients in order to improve 
inspiratory muscle function.  The literature has shown that the use of IMT has resulted in 
increased respiratory muscle performance, decreased dyspnea, and improved quality of 
life in patients with COPD who have used the technique daily (Basoglu et al, 2005; 
Petrovic et al., 2012; Geddes et al., 2005).  The early literature on the use of IMT with 
individuals with COPD had not been supportive of this intervention, which prompted the 
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Geddes et al. (2005) systematic review to examine the effects of IMT on inspiratory 
muscle strength, dyspnea, and quality of life in these individuals.  IMT was found to 
produce significant improvements in inspiratory muscle strength, dyspnea, and quality of 
life for this population.  Guidelines recommend the use of pulmonary rehabilitation in 
patients with COPD in order to reduce the frequency of exacerbations and improve the 
quality of life in these patients, with IMT being a modality of this.  The literature has 
shown that an incentive spirometer can be used to perform effective inspiration as a form 
of IMT in patients with COPD (Heydari et al., 2013).   
Limitations 
 There were several limitations that were found during the review of the literature.  
Geddes et al. (2005) and Heydari et al. (2013) noted that most of the participants in their 
studies were male, which doesn’t lend the findings applicable in most situations 
considering that COPD affects both male and female individuals.  Several of the studies  
noted small sample sizes which isn’t representative of the true population of COPD 
patients since a large number of patients are affected by the disease (Petrovic et al. 2012; 
Basoglu et al. 2005).  Most of the studies contained an intervention period from two to 
eight weeks, and this was a limitation noted by Heydari et al. (2013) because it didn’t 
provide the investigators with the opportunity to pursue the long term effects of the 
intervention.   
Conclusion 
 The GOLD guidelines recommend the use of pulmonary rehabilitation in patients 
with COPD in order to decrease exacerbations in this population.  IMT has been shown to 
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be effective in increasing inspiratory muscle function thereby decreasing dyspnea and 
improving quality of life.  COPD morbidity and mortality is increasing worldwide and a 
large majority of the population is afflicted by the disease.  The disease places a large 
burden on patients and the healthcare system and it is a significant problem in primary 
care (Heydari et al., 2013).  Implementing evidence based care such as IMT into direct 
clinical practice shows improved inspiratory muscle strength, decreased dyspnea, and 
improved health care quality of life in this population of patients (Basoglu et al., 2005; 
Heydari et al., 2013; Petrovic et al., 2012).  APN’s are in the ideal position to implement  
evidence based practices in this specific population of patients.  By including IMT in the 
plan of care for patients with COPD, this population will receive quality care and 
improved outcomes.  
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Chapter 3 
Organizational Framework of Conceptual Model for EBP Change 
 In today’s rapidly changing healthcare environment, healthcare professionals are 
typically very motivated to be evidence-based practitioners in order to ensure they 
provide high quality care (Melnyk & Fineout-Overholt, 2011).  Evidence-based 
practitioners are encouraged to consider internal evidence, the patients’ preferences and 
actions, healthcare resources, and clinical expertise when making clinical decisions 
(Melnyk & Fineout-Overholt, 2011).  Evidence based practice (EBP) is “the integration 
of best research evidence with clinical expertise and patient values to facilitate clinical 
decision making” (Melnyk & Fineout-Overholt, 2011, p. 242).  Evidence based practice 
is a problem solving approach to clinical care that incorporates the use of current best 
practice from well-designed studies, the expertise of clinicians, and the values and 
preferences of patients (Fineout-Overholt, Melnyk & Schultz, 2005).  When provided in a 
context of caring, EBP leads to the best clinical decision making and outcomes for 
patients and their families (Fineout-Overholt, Melynk & Schultz, 2005).  The Institute of 
Medicine (IOM) recognizes the importance of EBP and recommends its use as one of the 
five core competencies for healthcare (Fineout-Overholt, Melynk & Schultz, 2005).  
Advanced practice and staff nurses as well as administrators must have a foundational 
knowledge as well as strong beliefs about the importance of EBP and critical skills to 
support evidence-based care (Fineout-Overholt, Melynk & Schultz, 2005).   
 Even though EBP is important, changing clinical practice is complex and  
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challenging and because of this, conceptual models and frameworks have been developed 
to guide the implementation of EBP with a systematic approach (Melnyk & Fineout-
Overholt, 2011).  The Model for Evidence Based Practice Change by Rosswurm and 
Larrabee (1999) (Appendix A) is the conceptual model used in this evidence based 
practice change.  This evidence-based model is derived from theoretical and research 
literature related to evidence-based practice, utilization of research, and change theory 
(Rosswurm & Larrabee, 1999).  It was revised to integrate the principles of quality 
improvement, use of teamwork tools, and evidence-based translation strategies to 
promote the adoption of a new practice (Melnyk & Fineout-Overholt, 2011).   
 The model guides practitioners through the process of evidence-based practice 
change, beginning with the assessment of the need for a change practice, and ending with 
the integration of an evidence-based protocol (Rosswurm & Larrabee, 1999).  The model 
has six phases that include (1) assess the need for change in practice; (2) link the problem 
to interventions and outcomes; (3) synthesize the best evidence; (4) design a practice 
change; (5) implement and evaluate the change in practice; and (6) integrate and maintain 
the change in practice (Rosswurm & Larrabee, 1999). 
Conceptual Definitions 
Assess the need for change in practice.  Key actions in this step include identifying a 
practice problem or opportunity for improvement in practice, creating a team of 
stakeholders to address the problem in practice, collecting internal data about the 
practice, collecting external data to compare with the internal data, and linking the  
practice problem with possible interventions and desired outcomes  by developing a  
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clinical question (Melnyk & Fineout-Overholt, 2011).  It is important to justify the focus 
of the EBP project because these projects can become resource intensive (Melnyk & 
Fineout-Overholt, 2011).  The internal and external data collection may either 
substantiate current practice or support the need for the specific change in practice 
(Rosswurm & Larrabee, 1999).   
Link the problem interventions and outcomes.  Healthcare practitioners need to define 
the problem using standardized language and classifications and link the problem with 
interventions and outcomes (Rosswurm & Larrabee, 1999).  Using these classification 
systems facilitate communication among practitioners, provide standards for determining 
if care was of quality and cost-effective, and identify the needed resources (Rosswurm & 
Larrabee, 1999).  Key actions in this phase include identifying the types and sources of 
evidence, planning the search for evidence, and conducting the search for this evidence 
which should be planned and rigorous in order to find evidence of quality (Melnyk & 
Fineout-Overholt, 2011).  The types of quality evidence include practice guidelines, 
systematic reviews, randomized controlled trials, and expert committee reports (Melnyk 
& Fineout-Overholt, 2011).   
Critically analyze the evidence.  In this step, the selected interventions and outcomes 
are refined and the best evidence is synthesized and combined with clinical judgment 
(Rosswurm & Larrabee, 1999).  When critically appraising the literature, the practitioner 
evaluates the strengths and weaknesses of studies and identifies gaps in the available 
knowledge (Rosswurm & Larrabee, 1999).  The practitioner also assesses the feasibility, 
benefits, and risks of implanting the new practice (Melnyk & Fineout-Overholt, 2011).  
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After the synthesis of evidence, the members of the EBP team must judge whether the 
body of evidence is sufficient and strong enough to support the change in practice 
(Melnyk & Fineout-Overholt, 2011).   
Design practice change.  After the synthesis of the best evidence, practitioners describe 
the process variables or the sequence of activities in the change in practice and this 
usually is in the form of a protocol, procedure, or standard (Rosswurm & Larrabee, 
1999).  When considering a change, the practice environment, its resources, and feedback 
from stakeholders are important considerations (Rosswurm & Larrabee, 1999).  The 
protocol should only include activities that are evidence-based and it should be designed 
to guide care only for the populations that are similar to those identified in the evidence 
base (Rosswurm & Larrabee, 1999).  The evidence based is used in this step to guide 
practitioners in identifying the anticipated patient outcomes of the practice change 
(Rosswurm & Larrabee, 1999).  This is the step where needed resources should be 
identified and the implementation plan designed (Melnyk & Fineout-Overholt, 2011).   
Implementing and evaluating change in practice.  Key actions in this step include the 
implementation of the protocol; evaluating the process, outcomes, and costs; and 
developing conclusions and recommendations (Melnyk & Fineout-Overholt, 2011).  The 
implementation of the protocol will be more successful if the practitioner closely 
monitors its progress and is available to answer questions throughout and follow-up 
reinforcement of the practice change by the practitioner is essential (Rosswurm & 
Larrabee, 1999).  At the conclusion of the protocol, the data obtained are analyzed and 
disseminated in charts and graphs to facilitate the interpretation of the data and the  
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practitioner can then interpret the results to decide whether there were differences in the 
indicators before and after the protocol was administered (Rosswurm & Larrabee, 1999).  
Members of the EBP team can then use the data with verbal feedback to decide if the new 
practice should be adapted, adopted, or rejected based on the feasibility, risks, and 
benefits (Melnyk & Fineout-Overholt, 2011).   
Integrate and maintain change in practice.  If the results of the protocol support the 
change in practice, strategies to initiate the change begin (Rosswurm & Larrabee, 1999).  
Key actions of this step include sharing recommendations about the new practice with 
stakeholders, incorporating the new practice into the standards of care, monitoring the 
process and outcome indicators, and disseminating results of the project (Melnyk & 
Fineout-Overholt, 2011).  Continuing education and staff inservices facilitate the change 
in practitioners’ behavior and can reinforce the implementation of the new evidence-
based practice change (Rosswurm & Larrabee, 1999).  Plans should be made for ongoing 
monitoring of the change because this data can be used to identify the need for further 
refinements in the new practice or the need for a new EBP project (Melnyk & Fineout-
Overholt, 2011).  Maintaining the change in practice is ensured by providing practitioners 
with the necessary resources to implement the practice change, monitoring the process 
and outcomes, and by rewarding quality performance with incentives (Rosswurm & 
Larrabee, 1999).   
Relationship of Model to Project 
 When examining this model, it can easily be applied to this proposed evidence-
based practice project to facilitate the proposed change in practice for patients with 
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COPD.  This type of model can be applied in the primary care setting or any acute setting 
in order to facilitate a change in practice (Rosswurm & Larrabee, 1999).  The proposed 
practice change is to use incentive spirometry for daily inspiratory muscle training in 
patients with COPD in order to reduce the sensation of dyspnea and improve quality of 
life in these patients.   
 Individuals with COPD experience inspiratory muscle dysfunction and weakness 
due to the effects of increased work of breathing, hyperinflation, and hypoxemia which 
results in decreased respiratory muscle strength and significantly impairs quality of life 
for these patients (Geddes, Reid, Crowe, O’Brien & Brooks, 2005).  It is a major health 
problem in the United States with the mortality rate rising yearly (Halpern, Stanford & 
Borker, 2003).  In reviewing patient charts, discussions with patients presenting with 
frequent episodes of dyspnea, and through discussions with other clinicians and 
collaborators, the sensation of dyspnea and its impact on daily activities and health 
related quality of life was recognized as a problem within this population.  Knowing this, 
it was determined that a change in practice was needed when caring for patients with 
COPD.  Stakeholders included patients, practitioners, and administrators and the 
proposed practice change was discussed with all involved.  Internal and external data was 
collected regarding current problems in patients with the disease, cost and burdens 
associated with COPD and current practices in the treatment and management of the 
disease.  Data sources included patient charts, quality improvement data, and discussion 
with patients and caregivers.  Once collected, the data was compared to determine which 
intervention would be of benefit to these individuals to improve inspiratory muscle 
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strength, decrease dyspnea, and improve quality of life.  After analyzing the data, it was 
determined that impaired respiratory muscle strength was a problem in this population 
and that improvement in this area would be of great benefit to those with the disease.   
 Once the problem was identified, potential interventions were examined to 
determine which would be useful to this population and outcomes were determined to be  
a decrease in the sensation of dyspnea and the improvement of quality of life for these 
individuals.  The problem of decreased respiratory muscle strength was linked with the 
intervention of daily inspiratory muscle training with an incentive spirometer which was 
then included in a protocol for adult patients with COPD.  Outcomes identified were that 
of decreased sensation of dyspnea and improved quality of life as measured by a Visual 
Analogue Scale for breathlessness and the St. George’s Respiratory Questionnaire.   
 The literature was then reviewed, which focused on COPD, incentive spirometry, 
inspiratory muscle strength, quality of life, and dyspnea.  The obtained literature was then 
critically analyzed and placed on a table of evidence in order to evaluate the strength of 
the literature available.  The research evidence was then synthesized to determine which 
interventions were most effective for the desired outcomes in this population and the 
evidence was then combined with clinical judgment to determine the best possible 
intervention for these individuals.  The evidence determined that inspiratory muscle 
training significantly improved inspiratory muscle strength, decreased dyspnea, and 
improved the quality of life in patients with COPD and that an incentive spirometer was a 
common tool used for IMT (Basoglu, Atasever & Backagolu, 2005; Heydari, Farzad & 
Hosseini, 2013; Petrovic, Reiter, Zipko, Pohl & Wanke, 2012) Once the intervention was 
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determined, the feasibility, risks, and benefits of the intervention were determined in 
order for the intervention to be applied successfully in this population of individuals.  An 
incentive spirometer is an inexpensive and simple device that can be used at the bedside 
for inspiratory muscle training and also gives patients visual feedback to monitor and 
encourage their progress (Basoglu, Atasever & Backagoglu, 2005).   
 The proposed change in practice was defined and discussed with office 
practitioners, nursing staff, office managers, faculty mentor, and physician mentor.  
Needed resources were identified and incentive spirometers were obtained for use by the 
patients involved in the protocol.  Tools that would be used to measure outcomes were 
determined to be the Visual Analogue Scale for breathlessness and the St. George’s 
Respiratory Questionnaire (SGRQ).  Visual analogue scales for breathlessness were 
developed along with a daily symptom diary and the St. George’s Respiratory 
Questionnaire was obtained.  Nursing staff and stakeholders were educated in the use of 
the evidence-based protocol.   
 The evidence-based practice protocol was implemented in an outpatient care 
setting and the protocol was monitored throughout the entire process.  Data was collected 
and findings were analyzed to determine if the protocol was effective in this population 
and if the desired outcomes were met.  After analysis, findings supported the change in 
practice, and adoption of the protocol was recommended with minor revisions as needed.   
 A meeting was held with all stakeholders involved to review the protocol and 
proposed revisions if needed.  The evidence-based protocol was then presented to the 
hospital and practice administrators and information about the protocol and its results 
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were communicated to administrators and collaborating practitioners.  Inservice 
education was conducted with clinic staff about the protocol and its use.  An ongoing 
monitoring plan was devised to ensure quality outcomes for this population of patients 
and to revise protocol as needed.   
 Use of the Rosswurm and Larrabee (1999) model can prove to be beneficial in the  
development and implementation of this evidence-based practice protocol to provide 
quality care to adult individuals with COPD.  The model is easy to use and follows a 
systematic process in order to ensure successful implementation of the practice change.  
Today’s healthcare environment is supportive of evidence-based practice that will 
improve the quality of patient care and enhance clinical judgment and this framework can 
be useful to practitioners seeking to successfully change to evidence-based practice in a 
variety of healthcare settings (Rosswurm & Larrabee, 1999).  
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Chapter 4 
 Chronic obstructive pulmonary disease (COPD) is a common preventable and 
treatable disease that is characterized by persistent airflow limitation and currently affects 
about 1.5 million individuals (GOLD, 2014).  The airflow limitation is usually 
progressive and can substantially impair one’s quality of life and increase the risk of 
premature death (Petrovic, Reiter, Zipko, Pohl & Wanke, 2012).  Individuals with COPD 
experience inspiratory muscle dysfunction due to the increased work of breathing and 
hyperinflation, resulting in decreased inspiratory muscle strength and endurance, which 
presents as dyspnea (Geddes, Reid, Crowe, O’Brien & Brooks, 2005).  The airflow 
obstruction affects both the mechanical and gas exchange functions of the lungs and the 
respiratory muscles must work harder to overcome the resistance which leads to 
weakness of the respiratory muscles (Satani, Khuman, Devi & Nambi, 2013).   
 Inspiratory muscle training (IMT) is an important part of pulmonary rehabilitation 
which improves the strength and endurance of the respiratory muscles (Satani, Khuman, 
Devi & Nambi, 2013).  Incentive spirometry has been widely used as a form of 
inspiratory muscle training to improve inspiratory muscle strength and to reduce dyspnea 
(Satani, Khuman, Devi & Nambi, 2013).  IMT has also been associated with structural 
changes in the inspiratory muscle fibers (Geddes, Reid, Crowe, O’Brien & Brooks, 
2005).  Improving inspiratory muscle strength and endurance is a strategy that may help 
to relieve the sensation of dyspnea, which leads to an increased level of activity and 
improved quality of life in individuals with COPD (Geddes, Reid, Crowe, O’Brien & 
Brooks, 2005).  Improving the quality of life and decreasing dyspnea in these individuals  
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can lead to optimal outcomes in disease management.   
 This chapter will provide an overview of the planning stages and design of this 
evidence based practice project.  
Purpose of the Project 
 This evidence based practice change project was designed to improve the 
sensation of dyspnea and improve the quality of life in individuals with COPD.  The 
purpose of this project is to use incentive spirometry as IMT in conjunction with normal 
medical care to improve outcomes in this population.  IMT has been shown to decrease 
dyspnea and improve quality of life in these individuals, which thereby leads to increased 
productivity and decreased work days lost due to exacerbations of the disease.  The 
project will evaluate the effectiveness of implementing standard of care best practices in 
the care of patients with COPD.   
IRB Approval 
 Human Subjects Certification was completed through the National Institutes of 
Health on November 5, 2014 (Appendix B).  Misericordia University IRB forms and 
documentation to include participant consent forms, permission letter from 
institution/mentor to conduct the project, and data collection tools (St. George’s 
Respiratory Questionnaire and Visual Analogue Scale for Breathlessness) were 
completed in March 2015.  Institutional review board approval for the evidence based 
practice change project as a Type 1 review was granted through Misericordia 
University’s Institutional Review Board on May 11, 2015 (Appendix C).  
Potential Risks and Benefits 
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 There is a low potential risk with participation in this project and any risks for 
participation are the same as those for usual care.  The project does not involve the 
administration of any medications or other interventions that would expose the 
participants to unnecessary risks.  Benefits of this project may include symptom relief 
and the improvement in the quality of care for patients with COPD.  Participants will be 
provided education on the proper use and frequency of incentive spirometry.  The  
Advanced Practice Nurse (APN) who practices in the location where the project was 
conducted led the educational interventions.  There are vulnerable populations that are 
served by the clinical site, such as the underinsured and uninsured.   
Project Design 
 The evidence based practice change project, The Effectiveness of Implementing 
Standard of Care Best Practices Including Use of Daily Incentive Spirometry to Improve 
Dyspnea and Quality of Life in Adults with Chronic Obstructive Pulmonary Disease 
(COPD), was designed to be implemented at the time of visit to the urgent care setting 
for COPD patients experiencing the sensation of dyspnea and reporting a decreased 
quality of life.  Educational sessions were designed to last for a period of 30 to 60 
minutes, depending on patient participation and readiness to learn.   
 The Rosswurm and Larrabee (1999) Model for Change to Evidence-Based 
Practice was chosen to serve as the conceptual framework for the design of this evidence 
based practice change project.  The primary aim of the model is guide healthcare 
professionals through a systematic process for the change to evidence-based practice 
(Rosswurm & Larrabee, 1999).  The model guides practitioners through the entire 
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process of change in evidence-based practice, beginning with the assessment of need for 
the change and ending with the integration of an evidence-based protocol (Rosswurm & 
Larrabee, 1999).   
 Planning of the practice change project focused on methods to improve quality of 
life and dyspnea in patients with COPD.  Goals and objectives of the project were 
identified as the improved sensation of dyspnea, improved quality of life, and improved 
outcomes achieved in the care of these individuals.  
 The project plan was to identify those individuals with COPD upon presentation 
to the clinical site.  Once identified, these individuals were to be instructed on the use of 
incentive spirometry to improve inspiratory muscle strength and decrease dyspnea and 
improve quality of life.  The plan included patient instruction on the proper use and 
frequency of incentive spirometry.  Individuals were to be given the St. George’s 
Respiratory Questionnaire and Visual Analogue Scale for breathlessness to complete 
prior to their participation in the project and at the end of the project in order to assess the 
effectiveness of the intervention.  The plan included giving patients a daily symptom 
diary to keep track of their symptoms and also to assess compliance with the intervention.  
The plan included telephone calls to participants every two weeks for the duration of the 
project to ensure compliance and provide encouragement.  Prior to participation in the 
project, participants were required to sign informed consent.  
Data Collection Tools 
 The St. George’s Respiratory Questionnaire (SGRQ) (Appendix D) is a disease- 
specific instrument that was designed to measure impact on overall health, daily life, and  
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perceived well-being in patients with obstructive airway disease (St. George’s University 
of London, 2005).  It was developed and validated in patients with COPD and asthma  
(St. George’s University of London, 2005).  Test-to-test reliability has been shown to be 
0.795 to 0.900 and the questionnaire’s validity, reproducibility, and response to change 
over time have been demonstrated (Basoglu, Atasever & Backagolu, 2005; St. George’s 
University of London, 2005).  The tool has three components: symptoms, activity, and 
impact and the responses to these scores in these components can be aggregated into an 
overall score, from 0 to 100, with higher scores indicating a poorer quality of life 
(Basoglu, Atasever & Backagolu, 2005). The St. George’s University of London Medical 
School grants permission for clinicians to use the SGRQ free of charge (St. George’s 
University of London, 2005).   
 The Visual Analogue Scale (VAS) (Appendix E) is a tool to measure the intensity 
or frequency of various symptoms, including breathlessness (Dauphin, Guillemin, Virion 
& Briancon, 1999).  The VAS has been used for its simplicity and adaptability to a broad 
range of populations (Dauphin, Guillemin, Virion & Briancon, 1999).  It is more 
sensitive to small changes and is of most value when looking at changes within 
individuals (Dauphin, Guillemin, Virion & Briancon, 1999).  The VAS is available in 
public domain at no cost and its test-retest reliability has been shown to be reliable (0.90; 
95% CI; 0.88-0.92) (Badia, Monserrat, Rose & Herdman, 1999; Dauphin, Guillemin, 
Virion & Briancon, 1999).   
 The daily symptom diary (Appendix F) was created by this author as a way for 
participants to record their COPD symptoms on a daily basis and as a way for the patients  
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to keep track of their IMT performance.  
Resources Needed 
 Resources needed for the successful implementation of this evidence based 
practice change project include copy paper, ink cartridges, a printer to print out the initial 
SGRQ, VAS, and daily symptom diary, a copier to make copies for other participants in 
the study, a telephone line and telephone available to call participants every two weeks 
for compliance, an exam room in the clinical site to perform the education necessary for 
participation in the proposed project, incentive spirometers, and a medical assistant to 
obtain vital signs and place the participants in an exam room.  
Budget Justification 
 A budget is the financial expression of a project and should accurately reflect the 
costs of the proposed evidence based project and includes proposed direct costs, proposed 
indirect costs, and estimated program income (USF Health, 2015).  The proposed 
evidence based practice change project will not be receiving funding from any local, 
state, or federal governments or other outside sources.  No participants of the project will 
be provided with fringe benefits for their participation in the project.  Salaries and wages 
of the staff involved, which include the medical assistant and advanced practice nurse, 
are paid for by the clinical site.   
 The direct costs of the proposed practice change project include one case of copy 
paper at $27.29 per case, one set of printer cartridges in black ink at $35.99 per package, 
incentive spirometers from Voldyne Medical Corporation at approximately $7.98 each.   
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The total cost of incentive spirometers will vary depending on the amount of participants 
in the project.  If the project included twenty participants, the total estimated cost of the  
incentive spirometers would be $159.60.  Indirect costs include the time spent by the 
project mentor in supervising the project and offering services for mentorship during the 
project which are being provided by the project mentor as a voluntary effort.  
Summary 
 Improving inspiratory muscle strength and endurance is a strategy that may help 
to relieve the sensation of dyspnea, which leads to an increased level of activity and 
improved quality of life in individuals with COPD (Geddes, Reid, Crowe, O’Brien & 
Brooks, 2005).  Improving the quality of life and decreasing dyspnea in these individuals  
can lead to optimal outcomes in disease management.  The use of incentive spirometry 
and inspiratory muscle training has been shown to improve both muscle strength and 
endurance and improve the sensation of dyspnea in patients with COPD (Heydari, Farzad 
& Hosseini, 2013).  This project serves to implement standard of care best practices in 
the care of adults with COPD to improve outcomes in this population and to lead to 
improved disease management.    
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Chapter 5 
Implementation Procedures and Processes 
 According to GOLD (2014), non-pharmacologic therapies are used as adjunctive 
therapy in the treatment of individuals with COPD.  One of these therapies is known as 
pulmonary rehabilitation, which has a goal of reducing symptoms, improving quality of 
life, and increasing physical participation in everyday activities (GOLD, 2014).  
Inspiratory muscle training is a form of pulmonary rehabilitation. There are many 
benefits to pulmonary rehabilitation such as reduction of dyspnea, improved health 
related quality of life, reduced hospitalizations, and improved strength of respiratory 
muscles when IMT is used (GOLD, 2014).   This EBP change project attempted to 
strengthen the respiratory muscles in these individuals, leading to decreased dyspnea, 
improved quality of life, and improved outcomes in these patients.  
Setting for Practice Change 
 The setting for the project was a small outpatient clinic located in the Pocono 
Mountains of Pennsylvania.  Clinical staffing included three nurse practitioners, a 
collaborating physician, practice manager, office manager, and one medical assistant.  
Teaching activities were conducted in patient exam rooms, which provided for comfort 
and privacy during visits to the clinic.  Permission was obtained from the Practice 
Manager to conduct the project at the practice site (Appendix G).  The clinic was easily 
accessible to all participants and was handicapped accessible if needed, with ample 
parking.   
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Participants 
 Participants were adults, ages 45-70, with a diagnosis of COPD and who may be 
currently taking medications for their symptoms.  For inclusion in the project, patients 
had to be English speaking and medically compliant with treatment.  Participants would 
be required to read and sign the consent form prior to participation in the project 
(Appendix H).  
Justification of the Practice Change 
 The current clinical site for the implementation of the practice change has 
provided care to patients with COPD since its inception.  Many of these patients are on 
daily medications and treatment regimens for their disease yet continue to experience the 
effects of dyspnea and decreased quality of life.  The addition of inspiratory muscle 
training to the treatment regimens of these patients may lead to a decrease in dyspnea and 
improvement in their quality of life, leading to improved outcomes in the care of these 
patients.   
Implementation Procedures 
 The practice change project was implemented as described below. 
Phase I: After the EBP project was approved by the Institutional Review Board at 
Misericordia University, staff at the clinical site was educated on the purpose of the 
project and which patients would benefit from participation.  The training was conducted 
at the clinical site of the proposed practice change.  Only individuals with a diagnosis of 
COPD, who were ages 45-70, English speaking, and were known to be compliant with 
medical care were eligible for participation in the project.  
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Phase II: When patients meeting the inclusion criteria presented to the clinic with 
symptoms, the EBP project was explained to them in detail with the opportunity to ask 
questions.  Once they agreed to participate in the project, informed consent for a 
retrospective chart review was obtained.  Each participant completed a baseline SGRQ  
and VAS and was educated in the use of the incentive spirometer.  Participants were 
enrolled in the project on a rolling basis and were given daily symptom diaries to keep 
track of their symptoms and received follow up telephone calls every two weeks.   
Phase III: When each participant reached a participation period of eight weeks in the 
project, they were asked to complete a second VAS and SGRQ to gauge their symptoms 
and a retrospective chart review was performed to extract data for analysis.  Once all 
participants completed the study and data was extracted, an analysis of the data was 
performed.  
Task List with Timeline 
 A timeline for the project was developed to ensure that goals and objectives were 
successfully completed (Appendix I).  The timeline allowed for advanced preparation of 
project activities and to make adjustments to the project as needed.  A summarization of 
the timeline for the evidence based practice change project can be found in Appendix A.  
Summary 
 Implementation of this project targeted dyspnea and decreased quality of life, 
which are the most common symptoms that patients with COPD experience.  Improving 
these symptoms in these individuals allows them to live a more productive and 
meaningful life without the stressful burden that these symptoms create.  Incorporating 
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standard of care best practices in the routine care of individuals with COPD can lead to 
improved outcomes in this population. 
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Chapter 6 
Evaluation and Outcomes of Practice Change Project 
Clinical outcomes are used to measure the success of interventions and treatments 
in research and clinical trials.  Measurement of outcomes is important to determine and 
document the impact of the evidence-based practice change on patient outcomes (Melnyk 
& Fineout-Overholt, 2011).  Evaluation is an important component of the evidence based 
practice project because it determines the effectiveness of the intervention.  The purpose 
of this evidence-based practice project was to implement an evidence-based intervention 
from the literature to decrease dyspnea and improve quality of life in individuals with 
COPD.  This chapter describes the outcomes, statistical analysis of the data, comparison 
of the results to project objectives, and the evaluation of the evidence-based practice 
project.  
Expected Outcomes 
GOLD (2014) guidelines have established the primary goal for patients diagnosed 
with COPD is to reduce symptoms, reduce the frequency of exacerbations, improve 
health status, and restore effective daily functioning.  The expected outcomes of the 
evidence-based practice change project were based upon the premise of these guidelines.  
Expected outcomes were to improve the symptom of dyspnea and improve quality of life 
in individuals with COPD through the use of daily incentive spirometry.  
The Visual Analogue Scale (VAS) and St. George’s Respiratory Questionnaire 
(SGRQ) were tools used to measure the outcomes of dyspnea and quality of life for the 
evidence-based practice project.  The instruments, as described in Chapter Four, are a 
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self-reported scale and questionnaire that are condition specific to COPD.  The VAS 
addresses perceived level of breathlessness on a scale of one to ten.  The SGRQ is a 14 
item questionnaire that addresses the symptoms of the disease, the impact of the disease 
on the patient, and how the disease affects the patient’s activity level.   
Outcomes were evaluated based on the numerical scores from the VAS and the 
total scores from the SGRQ.  The evidence-based practice project was designed for 
participants, ages 45-70, with a diagnosis of COPD.  Ten individuals were approached 
regarding participation in the project, one refused.  The project was implemented with 
nine participants.   
The participants were examined and evaluated in the outpatient setting by this 
investigator.  The initial visit consisted of agreement to participate, instruction on the use 
and frequency of incentive spirometry, and completion of the VAS and SGRQ for 
baseline scores pre-intervention.  Telephone calls were placed to participants every two 
weeks to assess compliance.  At the end of the eight week intervention period, 
participants completed a post-intervention VAS and SGRQ.  At the end of the 
intervention period a retrospective chart review was also performed to determine if there 
was a decrease noted in the participant’s symptoms.   
Data Analysis and Results 
In accordance with published scoring instructions for the SGRQ, each positive 
answer was given a predetermined weighted score and a total score was determined by 
the addition of each positive score and dividing that number by the total possible score 
for the entire test, then multiplying the answer by one-hundred.  The VAS scores were 
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subjective numerical scores based on the sensation of symptoms pre- and post-
intervention.   
A significance level was established at 0.05 prior to implementation of the project 
to be considered effective and to weigh the strength of the evidence.  Data was entered 
into Excel when questionnaires were completed for pre- and post-intervention VAS and 
SGRQ scores.  Once all data were obtained, a two-tailed, paired t-test was performed 
through Excel to determine the effectiveness of the intervention.   
Improvement was noted in VAS scores of most participants, with a reduction of 
one to two points in eight participants noted after the intervention period (Appendix J).  
One participant did not note a change in the sensation of dyspnea during the protocol.  
The two-tailed p-value was less than the significance level of 0.05 and the t-value was 
2.306, which indicates statistical significance of the results and effectiveness of the 
intervention in decreasing dyspnea in patients with COPD (Table 1).  There was a 23% 
decrease noted in scores on the VAS after the use of IMT.  
Mean 1 SD 1 Mean 2 SD 2 p-value Percent 
Change 
5.22 1.30 4 0.87 0.0006 23% 
decrease in 
scores 
Table 1. Mean 1: The mean of pre-intervention scores; SD1: The standard deviation of pre-intervention  
scores; Mean 2: The mean of post-intervention scores; SD 2: The standard deviation of post-intervention 
scores. 
 
Improvement was noted in SGRQ scores of all participants at the end of the 
intervention period (Appendix J).  The two-tailed p-value was less than the significance 
level of 0.05 and the t-value was 2.31, which indicates statistical significance of the 
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results and effectiveness of the intervention in improving quality of life in patients with 
COPD (Table 2).  There was a 21% decrease in scores of the SGRQ after the use of IMT.   
Mean 1 SD 1 Mean 2 SD 2 p-value Percent 
Change 
51.9 17.8 40.9 16.1 0.00002 21% 
decrease in 
scores 
Table 2. Mean 1: The mean of pre-intervention scores; SD1: The standard deviation of pre-intervention  
scores; Mean 2: The mean of post-intervention scores; SD 2: The standard deviation of post-intervention 
scores. 
                                                                                           
Relationship of Results to Framework/Objectives 
An evidence-based practice project was implemented over an eight week period 
with COPD patients in the outpatient care setting.  The objective of the project was to 
implement an evidence-based practice protocol using incentive spirometry as a form of 
inspiratory muscle training when treating patients with COPD who present with dyspnea 
and impaired quality of life.  Measurement outcomes were identified and measurement 
tools were chosen.  Benchmarks for the measurement of outcomes were determined 
through literature review.   
The first defined outcome was a decrease in dyspnea in patients with COPD 
through the daily use of incentive spirometry.  Having achieved a reduction in VAS 
scores that was statistically significant is an encouraging finding that enables the practice 
change to be introduced into practice and expanded upon to optimize outcomes.   
The second defined outcome was improvement in quality of life in patients with  
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COPD through the daily use of incentive spirometry.  Having achieved a reduction in 
SGRQ scores that was statistically significant is encouraging, and enables the change to 
be introduced into practice to improve outcomes in this population.   
The findings of a positive correlation between a reduction in dyspnea and the use 
of daily incentive spirometry is not unexpected.  The implications of the need to add IMT 
to the plan of care for COPD patients became apparent as a result of this evidence-based 
practice project.  There are direct project implications that will make an impact locally 
with the COPD population.   
The Model for Evidence Based Practice Change by Rosswurm and Larrabee 
(1999) was the conceptual model used in this evidence-based practice change project.  
The model integrates the principles of quality improvement, use of teamwork tools, and 
evidence-based translation strategies to promote the adoption of a new practice (Melnyk 
& Fineout-Overholt, 2011).  It was determined that impaired respiratory muscle strength 
was a problem in patients with COPD and that improvement of this would be of great 
benefit to those with the disease.  Multiple interventions were explored through a review 
of the literature to determine which would be the most beneficial in this population and 
the use of incentive spirometry as a form of IMT was determined to provide significant 
improvement for both outcomes and the change was implemented in the practice setting.  
Once data is obtained from the protocol, it can be used as feedback to decide if the 
practice change should be adapted, adopted, or rejected based on the feasibility, risks, and 
benefits (Melnyk & Fineout-Overholt, 2011), which was done in this practice project. 
When analyzing the data, it was found that daily incentive spirometry did improve the 
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symptoms of dyspnea and quality of life in patients with COPD.  The improvement in 
dyspnea was found to be statistically significant for this population, however, the 
improvement in quality of life was found to not be statistically significant for this project 
population.  These results lead this investigator to question how the new practice should 
be adapted or revised in order to provide more significant results and implemented into 
everyday practice.  A potential revision for the project would be to implement the change 
in a larger population in order to get a sample size that is may show more of an effect 
from the intervention.  Another revision for the project would be to implement the change 
for a longer period of time such as twelve weeks or sixteen weeks, which would provide 
information regarding the long term effects of the intervention in this population.   
Today’s healthcare environment is supportive of evidence-based practice that will 
improve the quality of patient care and enhance clinical judgement and this practice 
change project has the potential to do just that.  With some minor revisions, this 
evidence-based practice change project has the potential to improve the quality of care in 
patients with COPD and lead to improved outcomes and standards of care.  
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Chapter 7 
 The profession of nursing involves the protection, promotion, and optimization of 
health, prevention of illness and injury, alleviation of suffering through the diagnosis and 
treatment of human response, and advocacy in the care of individuals, families, 
communities, and populations (American Nurses Association (ANA), 2015).  Advanced 
practice nursing is defined as: 
Any form of nursing intervention that influences health care outcomes for 
individuals or populations, including the direct care of individual patients, management of 
care for individuals and populations, administration of nursing and health care 
organizations, and the development and implementation of health care policy (AACN, 
2006, p. 4). 
The Doctor of Nursing Practice (DNP) graduate is prepared to investigate and 
solve problems facing our healthcare system and to deliver the highest level of nursing 
practice in order to achieve optimal outcomes (Zaccagnini & White, 2014).  The DNP 
must be constantly aware of and knowledgeable about changes in practice to ensure that 
current best practice is maintained (Zaccagnini & White, 2014).  
 This chapter will discuss the strengths and limitations of the evidence-based 
practice project, the implications for nursing practice, and the linkage of the project to the 
eight Essentials of Doctoral Education for Advanced Nursing Practice introduced by the 
AACN (2006).   
Limitations of the Project 
 It should be noted that there was a significant decrease in the number of patients 
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seen within the population of interest once implementation of the project began in late 
May.  A larger sample size may have yielded more positive results and may have been 
more representative of the population of interest.  The project proceeded despite the 
limited number of patients presenting with symptoms of COPD.  Another limitation of 
the project was the limited time period of 12 weeks within which to complete the project.  
If individuals presented with symptoms of COPD after the enrollment period, they were 
excluded due to the inability to perform the intervention for a period of eight weeks.  
Replication of the project for an extended period of time such as four to six months may 
strengthen the evidence based practice project and provide information regarding the long 
term effects of the intervention.  Extension of the end age range of participants from 70 to 
80 may provide for more participants in future projects, lending strength to the practice 
change project.  
Implications for Nursing Practice 
 DNP prepared nurses have the ability to integrate nursing science with knowledge 
from other areas such as ethics, the biophysical, psychosocial, analytical, and 
organizational sciences and use it as the basis to provide the highest level of nursing 
practice (AACN, 2006).  Strategies are needed to improve care delivery in individuals 
with COPD.  The DNP possesses a wide array of knowledge from the sciences and has 
the ability to translate that knowledge to effectively benefit patients in the daily demands 
of the practice environment (AACN, 2006).   
 All of the participants of this evidence based practice project were on daily 
medications for their COPD and still experiencing symptoms daily, yet not one has ever 
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participated in a pulmonary rehabilitation program or performed inspiratory muscle 
training at an attempt to improve their symptoms.  The current state of management of 
COPD consists of a multidisciplinary approach to patient care and pulmonary 
rehabilitation is now being recognized as an important part of the management of patients 
with COPD (Shinde, Kiran, Khatari & Hande, 2012).  The APN plays a key role in the 
identification of potential candidates for pulmonary rehabilitation and in facilitating and 
reinforcing the material learned in order to ensure optimal outcomes in this population 
(Heydari, Farzad & Hosseini, 2013).  Patients with COPD experience respiratory muscle 
weakness which may contribute to dyspnea being considered the most debilitating 
symptom in these patients (Heydari, Farzad & Hosseini, 2013).  Using incentive 
spirometry for inspiratory muscle training is an important component of the routine 
rehabilitation protocol for patients with COPD and can greatly enhance the APN’s ability 
to provide COPD patients with quality, accessible care and improve outcomes in this 
population (Heydari, Farzad & Hosseini, 2013).   
Linkage to DNP Essentials 
Essential I: Scientific Underpinnings for Practice. The DNP possesses a wide array of 
knowledge gained from the sciences and has the ability to quickly and effectively benefit 
patients in the daily demands of today’s practice environments (AACN, 2006).  The DNP 
is able to use science-based theories and concepts in order to determine the nature and 
significance of health and healthcare delivery phenomena, describe actions and advanced 
strategies to enhance, alleviate, and improve health and healthcare delivery in 
populations, and evaluate outcomes (AACN, 2006).  This evidence based practice project 
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used scientific evidence combined with concepts and theories to enhance and improve 
care delivery in individuals with COPD.  The Model for Change to Evidence-Based 
Practice by Rosswurm & Larrabee (1999) was used to guide the APN through a 
systematic process for change to the standard of care that was provided to individuals in 
this population.  Evidence was obtained from various sources in support of the use of 
IMT to decrease dyspnea and improve quality of life in individuals with COPD and was 
used to plan and implement the evidence based practice project.  
Essential II: Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking. Using organizational and systems leadership is important to improve 
patient and healthcare outcomes (AACN, 2006).  Using the knowledge and skills of the 
DNP in these areas is consistent with nursing goals to eliminate health disparities and to 
promote excellence in practice (AACN, 2006). In order to improve outcomes in 
populations, the DNP must be proficient in quality improvement strategies and have the 
ability to evaluate the cost-effectiveness of care in order to ensure effective care delivery 
strategies (AACN, 2006).  COPD is a disease that affects individuals of all 
socioeconomic classes but poverty has been shown to be a risk factor for development of 
the disease (GOLD, 2014).  The disease can occur as a result of the individual’s 
environment and may be prevalent where health disparities occur.  The incentive 
spirometer is an inexpensive, simple device that can be used to perform IMT and can be 
used to improve outcomes in this population and enhance access to care.   
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice. 
The DNP prepared nurse is able to translate research into practice and use analytical 
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methods to critically appraise existing literature to determine and implement the best 
evidence for practice (AACN, 2006).  A methodical search of healthcare databases 
resulted in evidence that supported the use of IMT in patients with COPD in order to 
improve dyspnea and improve quality of life.  Through critical analysis, only the  
strongest and most reliable evidence was chosen to support this practice change project.  
The evidence obtained was then used to design, direct, and evaluate quality improvement 
methodologies to promote safe, timely, effective, and quality patient-centered care.  
Essential IV: Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Healthcare. The knowledge of information systems 
and technology allows the DNP to apply new knowledge, manage individual and 
aggregate level information, and assess the efficacy of patient care technology (AACN, 
2006).  The ability to design and use information systems and technology to evaluate 
programs of care and outcomes of care is an essential skill of the doctorally prepared 
nurse (AACN, 2006).  Information systems and technology were used in this practice 
change project in order to determine the impact that COPD has within populations, 
design an evidence-based intervention, predict and analyze outcomes, and identify gaps 
in evidence for practice.  Data analysis was performed using information technology in 
order to evaluate the outcomes of this project.  It was predicted that daily use of IMT in 
individuals with COPD would result in decreased dyspnea and improved quality of life in 
this population and through analysis of the data, it was determined that there was an 
improvement in symptoms in patients who participated in the evidence-based practice 
project.   
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Essential V: Health Care Policy for Advocacy in Health Care. Health care policy can 
facilitate or impede the delivery of healthcare services or the ability of the provider to  
engage in practice to improve health care needs (AACN, 2006).  It is important that the 
DNP is able to design, implement, and advocate for healthcare policy that addresses 
issues of social injustice and equity in healthcare (AACN, 2006).  This evidence based 
practice change project applied a cost-effective intervention that can be used in areas of 
health disparities in order to improve healthcare outcomes within the population, thereby 
eliminating social injustice in the delivery of healthcare.  The results from this practice 
change project can be used to educate others regarding improving outcomes in patients 
with COPD.  
Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes. Today’s healthcare environment depends on contributions from highly 
skilled and knowledgeable individuals from multiple professions in order to accomplish 
the Institute of Medicine’s (IOM) mandate for safe, timely, effective, efficient, equitable, 
and patient-centered care (AACN, 2006).  This evidence-based practice change project 
occurred as part of a collaborative effort involving various staff members in the clinical 
setting in order to improve the standard of care provided to patients with COPD.  
Effective communication and leadership skills were employed to lead the 
interprofessional team in implementation of the EB project and improving population 
health outcomes.  
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s 
Health. The implementation of clinical prevention and population health activities is  
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central to achieving the national goal of improving the health status of the population of 
the United States (AACN, 2006).  The DNP can engage in leadership to integrate  
evidence-based clinical prevention and population health services for individuals and 
populations (AACN, 2006).  Data were evaluated that show the incidence and prevalence 
of COPD is higher in populations with lower socioeconomic status and that regardless of 
socioeconomic status, COPD is becoming an ever increasing social and financial burden 
in the United States.  When evaluating patient records, it was determined that many of the 
patients with COPD have never been involved in any form of pulmonary rehabilitation 
and continue to present with symptoms of the disease.  This information was used to 
develop an evidence-based practice change project focusing on a cost-effective form of 
IMT that can be used by anyone diagnosed with COPD in order to improve healthcare 
outcomes in populations and address gaps in care.   
Essential VIII: Advanced Nursing Practice. The DNP is able to design, implement, and 
evaluate therapeutic interventions based on nursing science as well as develop and sustain 
therapeutic relationships and partnerships with patients and other professionals to 
facilitate optimal care and patient outcomes (AACN, 2006).  A therapeutic relationship 
was developed with each participant in order to ensure their trust in the information and 
care provided to them.  The evidence-based practice project was designed to be simple 
and easy to apply in any type of practice setting.  Once a patient met inclusion criteria, 
the project was explained to them in detail with the opportunity to ask questions.  They 
were then instructed on the protocol and evaluated at the beginning and end of a period of 
eight weeks.  A retrospective chart review was then performed to determine if an 
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improvement in daily symptoms was seen. Through participation of the participants in 
the protocol, improvement was shown in the standard of care for patients with COPD.  
Summary 
 COPD is a leading cause of morbidity and mortality worldwide and results in an 
economic and social burden that is substantial and increasing, which makes control of 
symptoms and improvement of outcomes important (GOLD, 2014).  There are various 
therapeutic treatment options for COPD encompassing pharmacologic and non-
pharmacologic therapies, and IMT has been found to be beneficial to patients with COPD 
when used as part of a pulmonary rehabilitation program (GOLD, 2014).  The principal 
goals of a pulmonary rehabilitation program are to reduce symptoms, improve quality of 
life, and increase physical and emotional participation in everyday activities (GOLD, 
2014).  The DNP has the ability to investigate and solve the problems facing our 
healthcare system today and deliver the highest level of nursing practice in order to 
achieve optimal outcomes (Zaccagnini & White, 2014), which would be essential in the 
care of individuals with COPD.  Findings from this project determined a need to include 
the use of IMT in the care plan of individuals with COPD, along with pharmacologic 
therapies, in order to improve outcomes and the standard of care in this population.  The 
results of the project also confirmed evidence from existing literature that using IMT can 
improve dyspnea and improve quality of life in these patients.  The DNP can design, 
direct, and implement quality improvement activities to promote safe, timely, effective, 
and patient-centered care and must be constantly aware of and knowledgeable about 
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changes in practice to ensure that current best practice is maintained (AACN, 2006; 
Zaccagnini & White, 2014).  
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Chapter 8 
Summary and Conclusions 
  The symptoms of dyspnea and decreased quality of life can be frustrating 
to individuals with COPD.  The desired outcome of this evidence-based practice project 
was to improve these symptoms in COPD patients with evidence supported IMT and 
improve outcomes in this population.  
 The implementation of this project involved a change in practice based upon the 
best evidence available.  A review and analysis of the literature indicated that individuals 
with COPD can strengthen their respiratory muscles through IMT.  Evidence from major 
studies supports the use of IMT in patients with COPD to improve quality of life and 
decrease dyspnea.  COPD may be treated with systemic corticosteroids, inhaler 
corticosteroids, and long and short acting beta-agonists, however, many individuals 
continue to experience daily symptoms of the disease.  GOLD (2014) guidelines 
recommend pulmonary rehabilitation as a form of adjunct therapy in these patients and 
IMT is an aspect of this.   
 This practice change project arose out of a need to improve standard of care best 
practices for COPD patients.  Many patients were presenting to the outpatient setting with 
complaints of symptoms and frequent exacerbations, leading to increased healthcare costs 
and patient dissatisfaction with care.  Planning of the project with preceptor and clinician 
involvement began seven months prior to implementation of the project.   
 Development of the protocol provided guidance for the implementation of the 
intervention and required the clinician and staff to explain the use and frequency of 
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incentive spirometry and request that participants complete an SGRQ and VAS for a pre-
intervention baseline. 
 Based on project evaluation data, this project accomplished the intended 
outcomes as evidenced by the improved VAS and SGRQ scores.  There was at least a one 
point improvement in every participant’s VAS scores, and activity scores improved in 
patients that were involved in the protocol.   
 The successful implementation of this project indicates that evidence-based 
practice projects can be used to improve the standard of care provided to COPD patients.  
The strategic planning of the project with all staff involved alleviated barriers to 
implementation.  Using the Model for Change to Evidence Based Practice by Rosswurm 
& Larrabee (1999) enabled the change to be implemented smoothly. 
 There is an abundance of research available on the care of COPD patients but 
there is limited research on the use of IMT and incentive spirometry to improve 
symptoms in COPD patients.  The limited research conducted on the use of IMT for 
symptom improvement in COPD patients indicates an opportunity for future research in 
this area. The treatment protocol developed for this project is based on the best available 
scientific evidence and may be replicated in other practice settings and by disciplines 
other than nursing.  
 By developing a treatment protocol for adult patients with COPD, treatment 
recommendations were appropriate for all ages of individuals with this disease.  This 
project resulted in a reduction of symptoms and improved quality of life, leading to 
improved outcomes and the provision of optimal care to patients with COPD.  
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Dissemination Plans 
 Dissemination of nursing knowledge is essential for APN’s (Hanrahan, Marlow, 
Aldrich & Hiatt (2010).  In order to maintain the highest standards of care, nurses need to 
be aware of the most recent and relevant research and use this knowledge to inform their 
practice (Cheek, Gillham & Ballantyne, 2005).  Being able to contribute, effectively use, 
and communicate knowledge to nurses, colleagues, policy makers, and the public via 
publications, posters, and presentations is crucial for the profession of nursing (Hanrahan, 
Marlow, Aldrich & Hiatt (2010).   
 Dissemination plans for this evidence-based practice project include a discussion 
of the results with other colleagues involved in the care of individuals with COPD, the 
implementation of IMT in current practices for COPD, submission of a manuscript of the 
project for publication in nursing journals, the implementation of a journal club in the 
practice site once per month after the staff meeting, and a discussion of the project results 
with local COPD patients through seminars and workshops. The dissemination of results 
from this evidence-based practice project can improve the standard of care for individuals 
with COPD as well as lead to improved outcomes in this population.   
Future Ideas/Next Steps Related to Project 
 Future ideas for this evidence-based practice project include the implementation 
of IMT in practice with all patients with a diagnosis of COPD.  Patients outside of the 
project age range of 45-70 may also benefit from use of IMT.  Even the slightest 
improvement in symptoms may be meaningful to these individuals.  Another thought is to 
vary the length of the project, with a potentially shorter intervention period of four weeks 
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to determine if participants would see improvement in their symptoms in a shorter period 
of time.  Consideration should also be given to extending the length of the intervention 
period to twelve weeks to determine if there is a greater benefit to patients when using 
IMT for a longer period of time.  Various studies (Heydari, Farzad & Hosseini, 2013; 
Satani, Khuman, Devi & Nambi, 2013) have suggested lengthening the intervention 
period to determine the long term effects of IMT in this population, to determine if IMT 
with incentive spirometry has a more permanent effect on pulmonary functions, reduced 
exacerbations, and the reduced frequency of use of bronchodilators.  The short period of 
eight weeks only shows the short term, immediate effects of the intervention.   
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Appendix A 
 
 
The Rosswurm and Larrabee Model for EBP Change 
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Appendix B 
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Appendix C 
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Appendix D 
ST. GEORGE’S RESPIRATORY QUESTIONNAIRE for COPD patients 
(SGRQ-C) 
This questionnaire is designed to help us learn much more about how your breathing is 
troubling you and how it affects your life. We are using it to find out which aspects of 
your illness cause you most problems, rather than what the doctors and nurses think your 
problems are. 
Please read the instructions carefully and ask if you do not understand anything. Do not 
spend too long deciding about your answers. 
ID: __________________________ 
Date: ______/________/________ (dd/mm/yy) 
Before completing the rest of the questionnaire: 
Please select one box to show how you describe your current health: 
Very good  
Good  
Fair  
Poor  
Very poor  
Version: 1st Sept 2005 
Copyright reserved P.W. Jones, PhD FRCP Professor of Respiratory Medicine, St. 
George’s University of London, Cranmer Terrace London SW17 ORE, UK. 
Tel. +44 (0) 20 8725 5371 Fax +44 (0) 20 8725 5955 
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UK/ English version COPD 
SGRQ-C - United Kingdom/English SGRQ-C_AU1.0_eng-GBori.doc 
St. George’s Respiratory Questionnaire PART 1 
Questions about how much chest trouble you have. 
Please select ONE box for each question: 
Question 1. 
I cough: 
most days a week........................  a 
several days a week....................  b 
only with chest infections...........  c 
not at all......................................  d 
Question 2. I bring up phlegm (sputum): 
most days a week........................  a 
several days a week....................  b 
only with chest infections...........  c 
not at all......................................  d 
Question 3. I have shortness of breath: 
most days a week........................  a 
several days a week....................  b 
not at all......................................  c 
Question 4. I have attacks of wheezing: 
most days a week........................  a 
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several days a week....................  b 
a few days a month.....................  c 
only with chest infections...........  d 
not at all......................................  e 
Question 5. How many attacks of chest trouble did you have during the last year? 
3 or more attacks ........................  a 
1 or 2 attacks...............................  b 
none............................................  c 
Question 6. How often do you have good days (with little chest trouble)? 
no good days...............................  a 
a few good days..........................  b 
most days are good.....................  c 
every day is good........................  d 
Question 7. If you have a wheeze, is it worse in the morning? 
no................................................  
yes...............................................  
St. George’s Respiratory Questionnaire PART 2 
8. How would you describe your chest condition? 
Please select ONE: 
Causes me a lot of problems or is the most important problem I have .........  a 
Causes me a few problems ...........................................................................  b 
Causes no problem........................................................................................  c 
75 
 
 
9. Questions about what activities usually make you feel breathless. 
For each statement please select the box that applies to you these days: 
                                                                                                                 True False 
Getting washed or dressed......................................................................   a 
Walking around the home........................................................................   b 
Walking outside on the level....................................................................   c 
Walking up a flight of stairs......................................................................   d 
Walking up hills........................................................................................   e 
10. Some more questions about your cough and breathlessness. 
For each statement please select the box that applies to you these days: 
                              True False  
My cough hurts.....................................................................................   a 
 My cough makes me tired ....................................................................   b  
I am breathless when I talk...................................................................   c 
 I am breathless when I bend over ........................................................   d  
My cough or breathing disturbs my sleep.............................................   e 
             I get exhausted easily...........................................................................   f 
11. Questions about other effects that your chest trouble may have on you. 
For each statement please select the box that applies to you these days: 
                                                                                                                   True False 
 My cough or breathing is embarrassing in public.................................   a 
My chest trouble is a nuisance to my family, friends or neighbours.....   b 
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I get afraid or panic when I cannot get my breath................................   c 
I feel that I am not in control of my chest problem................................   d 
I have become frail or an invalid because of my chest.........................   e 
Exercise is not safe for me...................................................................   f 
Everything seems too much of an effort...............................................   g 
12. These are questions about how your activities might be affected by your breathing. 
For each statement please select the box that applies to you because of your 
breathing:                                                                                     True False 
 I take a long time to get washed or dressed...........................................   a  
I cannot take a bath or shower, or I take a long time.............................   b 
 I walk slower than other people, or I stop for rests.................................   c  
Jobs such as housework take a long time, or I have to stop for rests....   d 
If I walk up one flight of stairs, I have to go slowly or stop.....................   e 
 If I hurry or walk fast, I have to stop or slow down .................................   f 
My breathing makes it difficult to do things such as walk up hills, carrying things up 
stairs, light gardening such as weeding, dance, play bowls or play golf ....   g 
My breathing makes it difficult to do things such as carry heavy loads, dig the garden or 
shovel snow, jog or walk at 5 miles per hour, play tennis or swim...............  h 
13. We would like to know how your chest trouble usually affects your daily life. 
For each statement please select the box that applies to you because of your breathing:  
True False  
                I cannot play sports or games ................................................................   a 
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I cannot go out for entertainment or recreation......................................   b 
 I cannot go out of the house to do the shopping....................................   c 
 I cannot do housework ...........................................................................   d 
 I cannot move far from my bed or chair..................................................   e 
14. How does your chest trouble affect you? 
Please select ONE: 
It does not stop me doing anything I would like to do .................  a 
It stops me doing one or two things I would like to do.................  b 
It stops me doing most of the things I would like to do................  c 
It stops me doing everything I would like to do............................  d 
Thank you for filling in this questionnaire. 
Before you finish, would you please check to see that you have answered all the 
questions. 
 
 
 
 
 
 
 
 
 
78 
 
 
Appendix E 
VISUAL ANALOGUE SCALE FOR BREATHLESSNESS 
 
Please rate the severity of your daily sensation of  shortness of breath on this scale from 
1-10, with 1 meaning having no shortness of breath at all, 5 meaning moderate shortness 
of breath, and 10 being short of breath as bad as can be.  
 
 
 
 
                       _________________________________________________________ 
1          2          3          4          5          6          7          8          9          10 
                     No                                          Moderate                                               Severe  
                  Shortness                                 shortness                                            shortness 
    of breath                                    of breath                                                   of  
          breath 
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Appendix F 
Daily Symptom Diary 
Week 1 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
Week 2 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
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Day 7 
________________________________________________________________________ 
Week 3 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
Week 4 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
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Week 5 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
Week 6 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
Week 7 
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Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
Week 8 
Day 1 
________________________________________________________________________ 
Day 2 
________________________________________________________________________ 
Day 3 
________________________________________________________________________ 
Day 4 
________________________________________________________________________ 
Day 5 
________________________________________________________________________ 
Day 6 
________________________________________________________________________ 
Day 7 
________________________________________________________________________ 
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Appendix G 
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Appendix H 
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Appendix H (con’t.) 
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Appendix I 
Timeline for Evidence Based Practice Change Project 
 Oct 
2014 
Nov 
2014 
Dec 
2014 
Jan 
2015 
Feb 
2014 
March 
2015 
April 
2015 
May 
2015 
June 
2015 
July 
2015 
August 
2015 
Project Stage            
Practice Change 
Identified 
           
Review of 
Literature 
           
Organizational 
Framework 
           
Planning            
Project Design            
Project 
Development 
           
IRB approval            
Implementation            
Project 
Implementation 
           
Data 
Compilation 
           
Evaluation            
Data Analysis            
Interpretation of 
Results 
           
Dissemination            
Presentation of 
Results 
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Appendix J 
 
  Figure 1. Visual Analogue Scale Scores Pre- and Post-Intervention 
 
 
       Figure 2. St. George’s Respiratory Questionnaire Results Pre- and Post-Intervention 
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